CSL and self-amplifying mRNA (sa-mRNA) pioneer Arcturus Therapeutics today announced ... Vaccines Innovation Unit, CSL. "Today's approval further demonstrates CSL's promise to pursue, develop, and ...

Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc.

In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against Jim Cramer’s other must-watch stocks. In a recent episode of Mad Money, Jim Cramer traveled to ...

Carisma retains all rights in autoimmune disease beyond the two nominated Milestone marks a significant step toward producing mRNA vaccines in Canada by 2025 CAMBRIDGE, MA / ACCESSWIRE / September ...

Cartesian Therapeutics has a strong cash position after a $130 million equity raise, extending its runway to support upcoming ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any breaking news developments ...

After hours: 16 September at 19:59 GMT-4 ...

Eliminating fake vaccine news with pharmacist, nurse, and physician review. GSK plc recently announced topline Phase 3 clinical trial data for a combination regimen of two of its vaccines: the RSV ...

After hours: 18 September at 7:57 pm GMT-4 ...